Zahra Shafaee

New York City Health and Hospitals Corporation

Papers

Total Citations

H-Index

About

Zahra Shafaee is a rising researcher in oncology and clinical epidemiology, whose work focuses on the evolving landscape of gastric adenocarcinoma—a leading cause of cancer-related mortality worldwide. Her most-cited study, "Trends in Clinicopathologic and Treatment Outcomes in Patients with Gastric Adenocarcinoma in the United States Between 2004 and 2021," provides a comprehensive, population-level analysis of nearly two decades of patient data. This work illuminates critical shifts in tumor characteristics, staging, and therapeutic approaches, offering actionable insights for improving survival outcomes and guiding clinical decision-making. Although early in her career, Shafaee’s research has already garnered attention for its timely, data-driven approach to understanding disparities and trends in gastric cancer care. Her contributions are particularly valuable for oncologists and public health researchers seeking to refine treatment protocols and address gaps in healthcare delivery. As she continues to build her portfolio, Shafaee’s dedication to translating large-scale clinical data into meaningful prognostic and therapeutic advances marks her as a promising voice in gastrointestinal oncology.